Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion type Assertion NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_head.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion description "[Furthermore, when the TrkB tyrosine kinase was blocked with the Trk-specific inhibitor CEP-2563, or by neutralizing antibody to BDNF, sensitivity to chemotherapy was significantly increased.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_provenance.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion evidence source_evidence_literature NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_provenance.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion SIO_000772 12438236 NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_provenance.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion wasDerivedFrom befree-20140225 NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_provenance.
- NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_assertion wasGeneratedBy ECO_0000203 NP490085.RAPopoqIdJFGs7wp-TbaxK6kyqFRWaoJvNBrxZpOdyWNg130_provenance.